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Serial femtosecond crystallography (SFX) has opened a new era in crystallo-
graphy by permitting nearly damage-free, room-temperature structure determi-
nation of challenging proteins such as membrane proteins. In SFX, femtosecond
X-ray free-electron laser pulses produce diffraction snapshots from nanocrystals
and microcrystals delivered in a liquid jet, which leads to high protein
consumption. A slow-moving stream of agarose has been developed as a new
crystal delivery medium for SFX. It has low background scattering, is
compatible with both soluble and membrane proteins, and can deliver the
protein crystals at a wide range of temperatures down to 4C. Using this crystal-
laden agarose stream, the structure of a multi-subunit complex, phycocyanin,
was solved to 2.5 A˚ resolution using 300 mg of microcrystals embedded into the
agarose medium post-crystallization. The agarose delivery method reduces
protein consumption by at least 100-fold and has the potential to be used for a
diverse population of proteins, including membrane protein complexes.
1. Introduction
Serial femtosecond crystallography (SFX) is a novel structural
biology technique that allows challenging protein structures to
be solved from submicrometre/micrometre crystals at room
temperature (Chapman et al., 2011). In SFX, nanocrystals and/
or microcrystals are delivered in a liquid (DePonte et al., 2008)
or a viscous stream (Weierstall et al., 2014) into the beam path
of a hard X-ray free-electron laser (XFEL). XFEL radiation is
composed of femtosecond pulses typically delivered at a rate
of 1–120 Hz, and diffraction patterns are obtained before the
crystals are destroyed (Neutze et al., 2004; Barty et al., 2012).
SFX currently requires large data sets because the diffraction
patterns are acquired from individual randomly oriented
protein crystals. Most SFX experiments thus far have been
based on protein crystals delivered using a gas dynamic virtual
nozzle (GDVN), where the crystals are delivered to the X-ray
beam in their mother liquor (DePonte et al., 2008). The gas-
focused GDVN liquid jet moves at a velocity of 10–20 m s1,
which delivers crystals much faster than required to replenish
the protein crystals between X-ray pulses at a pulse repetition
rate of 120 Hz. Therefore, approximately only one out of
every 10 000 crystals is probed by the X-ray pulses (Weierstall
et al., 2014). This type of liquid jet can consume 10–100 mg of
protein for the collection of a complete data set, which is
particularly problematic for membrane proteins and other
proteins that can only be produced in small amounts.
Membrane proteins are an important class of proteins that
are of very high relevance in biology, compromising 60% of all
current drug targets (Hopkins & Groom, 2002). However,
structure determination of membrane proteins lags far behind
soluble protein structure determination, with less than 550
unique membrane protein structures determined so far out of
over 100 000 structures currently deposited in the PDB.
Membrane proteins are insoluble in water and therefore have
to be extracted from the membrane in the form of protein–
detergent micelles. Most membrane protein structures are
obtained by either crystallization in solution in the form of
protein–detergent micelles or crystallization in the lipidic
environment of the lipidic cubic phase (LCP), a method for
membrane protein crystallization pioneered by Landau &
Rosenbusch (1996). LCP is a liquid crystalline phase that
is spontaneously formed upon mixing monoacylglycerols
(MAGs) and water, producing a continuous three-dimensional
network of curved bilayers arranged into a cubic lattice with
two networks of interconnecting continuous aqueous channels
(Caffrey, 2015). The architecture of the lipid formation
encourages type 1 crystal packing and has similar properties to
the native cell membrane (Caffrey, 2015). Crystallization in
LCP has been successful for structure determination of a wide
range of membrane proteins, including microbial rhodopsins,
photosynthetic complexes, -barrels, enzymes, transporters,
ion channels and especially G-protein-coupled receptors
(GPCRs), a class of membrane proteins with high medicinal
impact (Cherezov, 2011). A new crystal delivery system has
ben developed for SFX which allows the delivery of crystals
grown in LCP to the XFEL beam (Weierstall et al., 2014). The
high viscosity of LCP results in a much slower flow rate of the
stream, thus drastically decreasing the net mass of protein
needed for structure determination by SFX. LCP as a delivery
medium has been successfully used to determine GPCR
structures using an XFEL (Liu et al., 2013; Fenalti et al., 2015;
Weierstall et al., 2014; Zhang et al., 2015). Crystallization of
membrane proteins in LCP has been highly optimized,
contributing to the structures of over 60 unique membrane
proteins to date (Caffrey & Cherezov, 2009). However, it has
been challenging to crystallize large multi-domain membrane
complexes in LCP owing to the curvature associated with the
lipid bilayer and the low diffusion constants of large
membrane protein complexes in LCP. To date, the majority of
membrane protein structures solved by X-ray crystallography
have been determined from crystals of protein–detergent
micelles grown in solution, which have also been successfully
used for SFX experiments (Chapman et al., 2011; Aquila et al.,
2012; Johansson et al., 2012, 2013; Kupitz et al., 2014). These
membrane protein crystals were delivered either with the
GDVN liquid injector (DePonte et al., 2008), requiring large
amounts of protein, the gel injector (lipidic cubic phase
injector; Weierstall et al., 2014) or an electrospinning injector
(Sierra et al., 2012), which uses less protein but uses high
electric fields which could be problematic for crystal stability.
To date, all membrane protein structures delivered in LCP
for SFX (Weierstall et al., 2014; Liu et al., 2013; Fenalti et al.,
2015; Zhang et al., 2015) have been based on crystals that were
grown in LCP. Mixing of membrane protein crystals grown in
the form of a protein–detergent micelle with LCP typically
leads to dissolution of the crystals, very likely caused by
partitioning of the detergent, which forms the protein–
detergent micelle, into the lipidic phase. This leads to deple-
tion of the detergent in the protein–detergent micelles in the
crystals, resulting in denaturation of the protein. Recently, two
other viscous media, a mineral oil-based grease and petroleum
jelly, have been described as alternative crystal delivery
carriers (Sugahara et al., 2015; Botha et al., 2015). The grease
mixture (Sugahara et al., 2015) has been used to deliver
crystals to the XFEL beam for SFX data collection of soluble
model proteins at the SPring-8 Compact Free Electron Laser
(SACLAXFEL), while petroleum jelly (Botha et al., 2015) has
been used to deliver lysozyme at the Swiss Light Source (SLS).
Both of these delivery methods have so far only been
demonstrated at ambient pressure and they produce signifi-
cant and undesirable Debye–Scherrer rings in the region of
3.77–5 A˚. No results have been presented to date that show
either medium to be suitable for the delivery of multi-protein
complexes or membrane proteins. Thus, it is highly desirable
to develop an inert medium for the delivery of both soluble
and membrane proteins to the XFEL beam at slow flow rates.
Here, we have explored and developed a new delivery
medium for SFX based on agarose. Agarose is a versatile
polysaccharide polymer. Extracted from seaweed, agarose
dissolves in water at high temperatures (above 85C) and
forms a network of helical strands upon cooling, resulting in
the formation of a gel material (Arnott et al., 1974). We show
here that crystals grown via traditional crystallization methods
(i.e. vapour diffusion and dialysis) can be embedded into
agarose post-crystallization and prior to injection. Crystal
delivery in agarose can be accomplished in an expansive
temperature range from 4 to 30C, allowing crystallization
conditions over a wide range of temperatures to be compatible
with crystal delivery. In contrast, Mebiol, a medium recently
suggested as a viscous carrier by Botha et al. (2015), is only
viscous at temperatures above 25C. We show here that
crystals of complex membrane proteins such as the photo-
synthetic protein complexes photosystem I (PSI) and photo-
system II (PSII) can be delivered in an agarose stream. Thus,
agarose has the potential to be a general crystal delivery
medium for SFX for both soluble and membrane proteins.
To test whether agarose could be used to deliver crystals of
large, multi-protein complexes, phycocyanin (PC) was chosen
as a model system. PC is a cyanobacterial antennae protein,
part of the light-harvesting complex, which channels excitation
energy to PSII, subsequently driving charge separation across
the thylakoid membrane, the membrane that contains PSI and
PSII. The PC complex forms a disc-like trimer in which each
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monomer is composed of two subunits,  and  (Schirmer et
al., 1985).
2. Materials and methods
2.1. Protein purification and crystallization
PC was isolated from Thermosynechococcus elongatus.
Briefly, the protein was obtained by disrupting a concentrated
suspension of cells using a microfluidizer at 124 MPa. The
resulting suspension was further purified by ultracentrifuga-
tion at 50 000g for 1 h, in which large particles and aggregates
were separated from the supernatant. The supernatant was
then concentrated using Amicon Ultra-15 spin filters (Milli-
pore, 100 kDa cutoff), in which most small cytosolic proteins
are separated as they flow through the filters. PC was crys-
tallized by free interface diffusion as described by Kupitz et al.
(2014) for PSII (Saridakis & Chayen, 2003). The precipitant
solution consisting of 1.0M ammonium sulfate, 40 mM 2-(N-
morpholino)ethanesulfonic acid (MES) pH 6.4 was added
dropwise at 1 ml s1 to an equal volume of protein solution
(15 mg ml1). Crystals of 1–5 mm in size formed after 1 d and
were confirmed via second-order nonlinear imaging of chiral
crystals (Kissick et al., 2011). Prior to embedding the crystals
in the agarose medium, the crystals were filtered through a
10 mm stainless-steel filter.
PSI was isolated and purified in principle as described by
Fromme & Witt (1998) and Hunter & Fromme (2011) using
crystallization at low ionic strength as the last purification step.
The crystals were stabilized in a low ionic strength buffer that
consisted of 5 mM MES pH 6.4, 0.02% -dodecylmaltoside
(-DDM). PSII was isolated and purified as described by
Kupitz et al. (2014). The concentrated protein was subjected
to a series of batch crystallization steps with decreasing
concentrations of precipitant, as described in Kupitz et al.
(2014). The crystals were permitted to grow for 24 h and
crystal growth was then terminated by the removal of the
supernatant and the addition of buffer containing low salt
(100 mM 1,4-piperazinediethanesulfonic acid pH 7.0, 5 mM
CaCl2, 10 mM tocopherol, 20% PEG 2000).
2.2. Preparation of the agarose and embedding of crystals
into the viscous medium
After a broad screening and optimization process, a solu-
tion of 5.6%(w/v) agarose and 30% glycerol was determined
to form the most stable extrusion stream. In order to obtain
these conditions after mixing, 7%(w/v) ultralow-gelling-
temperature agarose (Sigma–Aldrich, catalog No. A5030) was
dissolved in a solution of 30% glycerol and the crystallization
buffer in a 15 ml centrifuge tube and submerged in a water
bath filled with boiling water for 30 min. To draw up the
agarose into a 100 ml syringe (Hamilton, Model 1710), the
syringe was warmed by drawing up and quickly ejecting
boiling water 10–15 times (to ensure the integrity of the
syringe, we avoided dipping more than the needle in solutions
at temperatures higher than 80C). The agarose was then
drawn up from a 15 ml centrifugation tube that remained
submerged in the water bath. For PC, the agarose was
dissolved in 600 ml glycerol and 1.4 ml of a solution consisting
of 15% PEG 2000, 30 mMMgCl2, 75 mM HEPES pH 7.0. For
PSII, the agarose was dissolved in 600 ml glycerol and 1.4 ml
100 mM PIPES pH 7.0, 5 mM CaCl2, 16%(w/w) PEG 2000.
For PSI, the agarose was dissolved in 1.4 ml 5 mM MES pH
6.4, 0.02% -DDM, 600 ml 2.0M sucrose. In the case of data
collected at helium ambient pressure, 2 ml 5 mMMES pH 6.4,
0.02% -DDM was used. 20 ml of the boiling hot agarose
solution pertaining to the protein system was drawn up into a
syringe. The agarose was allowed to equilibrate to room
temperature for approximately 20 min before 5 ml protein
crystals were mixed throughout the agarose using a syringe
coupler (Cheng et al., 1998); at least 40 syringe-mixing
exchanges were performed or until the crystals were visually
homogenously distributed in the agarose medium.
2.3. Data collection
Data were collected using the CXI instrument at the Linac
Coherent Light Source at SLAC (Boutet & Williams, 2010). A
continuous stream of agarose with crystals embedded was
extruded from a 50 mm capillary into the X-ray interaction
region using the LCP injector (Weierstall et al., 2014) at a flow
rate of 160 nl min1.
2.4. Data processing
During 6 h of protein crystal screening experiments at
LCLS, diffraction patterns were collected from different
protein crystals (PC, PSI and PSII). PC was chosen as a model
system and a complete data set was collected from PC crystals
delivered in agarose medium in 72 min. The 513 848
detector readouts were background-corrected and the hits
were filtered out using Cheetah (Barty et al., 2014), yielding
41 100 diffraction patterns that contained 25 or more Bragg
spots (an average hit rate of 8%). 14 143 patterns were
indexed (i.e. an indexing yield of 34%) and integrated using
CrystFEL (White et al., 2012; Kirian et al., 2011) with a
hexagonal lattice type with unit-cell parameters a = b = 153.4,
c = 39.6 A˚ (see Table 1). The merohedral space group of the
research papers
IUCrJ (2015). 2, 421–430 Chelsie E. Conrad et al.  Inert crystal delivery medium for SFX 423
Table 1
Phycocyanin data statistics.
Values in parentheses are for the highest shell.
Wavelength (A˚) 1.33
Space group P63
Resolution (A˚) 29.5–2.5 (2.55–2.50)
Unit-cell parameters (A˚, ) a = b = 153.4, c = 39.6,
 =  = 90,  = 120
No. of crystal hits 41100
No. of indexed patterns 14143
Duration of data collection (min) 72
Unique reflections 18908
Reflections used in refinement 18871
hI/(I)i 3.2 (0.83)
Multiplicity 250.67 (12.5)
CC* 0.971 (0.487)
Rwork/Rfree (%) 18.7 (32.7)/25.5 (35.5)
Completeness (%) 99.82
Average B factor (A˚2) 38.34
crystals, P63, exhibited an indexing ambiguity which was
resolved by ambigator, an implementation within CrystFEL of
an algorithm related to that described by Brehm & Diederichs
(2014). We decided on a resolution cutoff at 2.5 A˚ based on
the multiplicity and the CC* value (Karplus & Diederichs,
2012; see Table 1). The merged data set (truncated at 2.5 A˚
resolution) was phased by molecular replacement (MR) using
phenix.phaser (McCoy, 2007) with PDB entry 4gy3 as the
search model (after removing waters and ligands). The MR
model was first refined using a segmented rigid-body protocol
in which each subunit was considered as a rigid entity using
phenix.refine. A total of ten cycles of positional, individual B-
factor refinement, including two cycles of simulated-annealing
refinement, were then performed. In this step, water molecules
were added and refined using phenix.refine at 2.5 A˚ resolution.
The refined structure resulted in an Rwork of 18.7% and an
Rfree of 25.5% (see Table 1 and Supplementary Table S1). In
order to demonstrate that agarose is a suitable delivery
medium for SFX data collection from soluble proteins and
various membrane proteins, we have also provided diffraction
patterns from PSI and PSII (see Supplementary Figs. S3 and
S4).
3. Results and discussion
For a viscous medium to be suitable for SFX, three primary
requirements must be met: the medium must maintain crystal
integrity, must form a stable and continuous stream and the
diffraction from the medium should produce minimal back-
ground scattering. Several viscous media were tested in order
to investigate their potential as a general viscous, non-
Newtonian, carrying medium, including tapioca corn starch,
gelatine, silica hydrogel, polyacrylamide, polyvinyl alcohol and
poly(ethylene oxide). None of these media established stable
streams. Initial tests using agarose
as a crystal delivery medium
showed signs of dehydration in
vacuum, leading to the formation
of ice as detected by X-ray
diffraction. To prevent freezing,
we tested several potential cryo-
protectants for crystal delivery in
high vacuum. From those
screened, we narrowed our
selection to glycerol, which also
increased the viscosity of the
agarose stream, a welcome side
effect that makes extrusion more
reliable. Different concentrations
of agarose and glycerol were
screened to optimize the extru-
sion conditions and 5.6% agarose
dissolved in 30% glycerol was
found to be the most suitable
medium because it formed a
stable, continuous stream and no
ice-crystal diffraction artefacts
were observed (Supplementary
Fig. S1).
The next challenge was to
explore the best way to embed
the crystals into the agarose. We
explored three ways to embed the
crystals into the agarose medium:
(i) the growth of crystals in
agarose, (ii) simple manual
mixing on a glass slide (as has
been used for the oil-based grease
method; Sugahara et al., 2015)
and (iii) the use of a syringe setup
(Fig. 1), which was originally
developed for the crystallization
of proteins in LCP (Cheng et al.,
1998; Caffrey & Cherezov, 2009).
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Figure 1
Diagram showing how the crystals are embedded into the agarose medium. (a) A dense pellet of crystals is
drawn up into a syringe, (b) the agarose solution (contained in a 15 ml centrifuge tube) is submerged in
boiling water until the agarose dissolves, the liquid agarose is drawn up into a warmed syringe and the
agarose is allowed to gel and equilibrate to room temperature, (c) the protein crystals and agarose syringe
are connected by a syringe coupler and (d) using the syringe coupler, the crystals are embedded throughout
the agarose by moving the plungers back and forth.
The growth of crystals in agarose has been described in the
literature as a method to slow down crystal growth and to
counteract effects such as sedimentation and convection that
influence the crystallization process under gravity (Bier-
tu¨mpfel et al., 2002). We first investigated the growth of PC
crystals in agarose. Owing to the large size of PC, its diffusion
constant is very low and crystal growth in agarose is very slow,
leading to the formation of few nuclei. Furthermore, no
nucleation occurred in agarose in the presence of 30%
glycerol even at very high protein concentrations
(>20 mg ml1). Although PC could not be crystallized directly
in the gel owing to its large size and low diffusion constant,
other proteins might be suitable for crystal formation inside
the agarose gel as demonstrated previously (Garcı´a-Ruiz et al.,
2001; Lorber et al., 2009).
While the growth of crystals of PC in agarose was very
difficult, we succeeded in embedding pre-grown crystals into
the agarose medium, which allowed a full SFX data set to be
collected from PC crystals delivered in agarose (Supplemen-
tary Fig. S2). The mixing of pre-formed crystals is therefore
suggested as the preferred method of crystal delivery in the
agarose stream, as it does not depend on the size of the protein
and allows pre-grown crystals to be delivered to the XFEL
beam. However, simple mixing of crystals with agarose leads
to an inhomogeneous distribution of crystals and further
problems, including partial drying of crystals, the formation of
crystals of salt or other precipitants and the loss of protein
crystals during transfer to the injector crystal reservoir. We
have therefore adapted the LCP syringe setup for embedding
crystals into the agarose medium, as shown in Fig. 1. In order
to stabilize the crystals, the agarose solution was prepared in
the crystallization buffer corresponding to each of the
proteins. The agarose was dissolved by vortex mixing the
mother liquor and glycerol (for sample delivery in vacuum)
with the agarose powder in a 15 ml centrifuge tube. The tube
was then submerged in a water bath of boiling water for
approximately 30 min. A syringe was then warmed by drawing
up boiling water from the water bath all the way through the
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Figure 2
Protein crystals before and after mixing with agarose. (a) PC microcrystals, (b) PC crystals after mixing with agarose (birefringent), (c) PSII microcrystals
(birefrigent), (d) PSII crystals after mixing with agarose (birefrigent).
syringe and quickly ejecting it 10–15 times. With the centrifuge
tube submerged in boiling water, 20 ml agarose was drawn up
into the heated syringe and allowed to cool to ambient
temperature. A second syringe was filled with 5 ml of the
highly concentrated PC crystal suspension (ideally 1011 crys-
tals per millitre) in the crystallization mother liquor (the same
mother liquor as used in the agarose preparation). The desired
high crystal densities can be achieved by either sedimentation
or low-speed centrifugation of the crystal suspensions prior to
mixing with the agarose medium (see x2 for details).
After the agarose had entered the gel phase in the syringe,
the syringes containing agarose and the protein crystals were
connected using a syringe coupler (Fig. 1; Cheng et al., 1998).
The crystals were then embedded into the agarose by alternate
movement of the two plungers, whereby the solutions moved
back and forth between the two syringes at least 40 times
(Supplementary Fig. S2), leading to the embedding of the
crystals in the agarose medium at a crystal density of 2 
1010 crystals per millitre. Owing to the dilution caused by
mixing of the agarose medium with the crystal suspension, the
medium becomes less viscous, and the initial percentage of
agarose must be increased to compensate for the dilution.
Thus, the initial agarose concentration was increased to 7%
agarose in order to achieve a final concentration of 5.6% after
mixing with the crystals.
We used the same procedure of embedding crystals of
soluble model proteins such as lysozyme and the large
protein–cofactor complex PC, as well as one of the largest and
most complex membrane protein complexes that has been
crystallized so far: PSII (a dimer of 700 kDa containing 38
protein subunits and more than 100 cofactors). Pictures of the
different crystals embedded in agarose are shown in Fig. 2 and
Supplementary Figs. S2 and S4. A large variety of different
precipitants commonly used for crystallization are compatible
with the agarose medium, including high salt concentrations as
well as polyethylene glycols (PEGs). Examples include 1M
NaCl, 1.25M ammonium sulfate, 0.2M CaCl2 and a large
range of PEGs commonly used for crystallization (PEG 400–
8000 at a concentration of up to 30%). The stability of the
agarose-based stream is a function of its specific viscoelastic
and surface-tension properties; notable variations were
observed over the range of protein crystal compositions
tested. The most stable stream was achieved with protein
crystals that contained high-molecular-weight PEGs (>2000)
as the precipitant. Furthermore, agarose is also compatible
with organic precipitants such as 2-methyl-2,4-pentanediol
(MPD). Dissolving the agarose in different precipitants in
some cases decreased the viscosity. In these cases, the agarose
concentration was adjusted to 9%, which increased the visc-
osity and the ability to form a stable stream. An especially
challenging case for crystal delivery in agarose was the large
membrane protein complex PSI (a trimer of 1080 kDa
containing 36 protein subunits and more than 300 noncova-
lently bound cofactors), which crystallizes at low ionic strength
without the addition of any salt or precipitant [Jordan et al.,
2001; Hunter & Fromme, 2011; Chapman et al., 2011; the final
crystallization buffer contained only 5 mM 2-(N-morpholino)
ethanesulfonic acid (MES) pH 6.4 and 0.02% -dodecyl-
maltoside (-DDM) detergent]. PSI crystals dissolve in the
presence of glycerol or salt and do not tolerate the addition of
any organic solvents or PEGs. To prevent the freezing of the
PSI crystals in the agarose stream in high vacuum, we stabi-
lized the PSI crystals by embedding them in agarose prepared
with the PSI crystallization buffer and with 0.6M sucrose.
After optimization of the crystallization buffer, PSI crystals
could be embedded into agarose and delivered to the XFEL
beam in agarose with suitable crystal delivery stream stability
using the crystallization buffer with sucrose described above in
9% agarose.
The agarose stream was tested using the Coherent X-ray
Imaging (CXI) instrument at the Linac Coherent Light Source
(LCLS) at the SLAC National Accelerator Laboratory in the
vacuum-chamber setup (Boutet et al., 2012) used for most of
the SFX experiments published to date. Most of the SFX data
were collected in the vacuum chamber, except for PSI, where
the data shown in Supplementary Fig. S4 were collected in a
new ambient-pressure setup with a helium environment. The
advantage of using an ambient-pressure setup is that freezing
by evaporative cooling is avoided. At ambient pressure
cryoprotectant is not essential as dehydration occurs much
more slowly than in vacuum.
The agarose stream relies on a high-velocity inert-gas
(nitrogen) sheath to center and stabilize the emerging crystal
jet extrusion (Weierstall et al., 2014). This stability is required
in order to reliably align the agarose stream with the XFEL
beam axis. We observed a higher stability of the stream in
vacuum compared with the ambient-pressure setup in the
helium atmosphere. The lower stability of the stream at
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Figure 3
Diffuse background scattering comparison between agarose and LCP. 1/d
(x axis) is plotted against the mean radial intensity over the total number
of frames used from each medium (y axis). The blue line represents the
mean radial intensity for LCP medium as a function of 1/d (or resolution
in A˚ on the second x axis). The green line represents the mean radial
intensity for agarose as a function of 1/d. The error or fluctuation in the
radial intensity is quantified using the mean absolute deviation for both
media, which is shown as a transparent gray region.
atmospheric pressure is presumably owing to a turbulent
boundary layer at the interface between the inert-gas sheath
stream and the surrounding ambient-pressure inert gas.
Furthermore, the background is higher in the He atmosphere
compared with the vacuum setup. For these reasons, vacuum
operation of the stream is preferred when freezing can be
avoided by the addition of PEG, glycerol or other cryo-
protectants. SFX data for PC and PSII were collected using
the vacuum-chamber setup and SFX data for PSI and PSII
were collected using the helium ambient-pressure setup as
described in x2.
Fig. 3 shows a comparison of the X-ray scattering from the
agarose stream compared with the LCP stream. We calculated
the average scattered intensity from each medium delivered in
a stream of the same width (50 mm) using detector-readout
events that contained no crystal diffraction. We analysed
13 902 frames from the agarose stream data and 14 592 frames
from the LCP stream data. Frames that contained no scat-
tering from the jets/streams (owing to the jet/stream
temporarily fluctuating out of the path of the X-rays) were
easily recognized on the basis of their very low photon counts
(10–20 detector units) and were excluded from the mean
background calculation, leaving 9147 and 8326 frames with
scattering from the LCP and agarose jets, respectively.
Thereby, bias from large jet/stream flow instabilities was
avoided in the calculation of the mean radial intensities for
each medium. To reduce the influence of shot-to-shot varia-
tions in the XFEL pulse intensities, each frame was scaled to
the readings from the gas-ionization detector upstream of the
vacuum chamber at the CXI. Finally, the mean radial inten-
sities from the LCP and agarose jets were scaled to be equal at
a resolution of 2 A˚, where neither medium should produce a
background signal. As shown in Fig. 3, a broad peak corre-
sponding to diffuse scattering from the lipid chains of LCP can
be seen at 4.5 A˚ resolution. Diffuse scattering from agarose
can be seen in the 3.3 A˚ region. The gray regions represent the
mean absolute deviation around the mean. Overall, the
background scattering from the agarose medium is roughly 2.3
times less than that from LCP in the diffuse-ring regions.
Furthermore, LCP scatters strongly at very low resolution
(>30 A˚), while the low-angle scattering is very low in the
agarose medium owing to the lack of long-range order and
thus is ideal for large unit cells (Lawrence et al., 2015). Indeed,
LCP (Weierstall et al., 2014; Liu et al., 2013), mineral oil-based
grease (Sugahara et al., 2015) and petroleum jelly (Botha et al.,
2015) all result in higher background scattering than agarose,
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Figure 4
Single diffraction pattern of PC in agarose measured using the CXI at LCLS, with the red box magnified in (b) and predicted peak positions circled after
indexing with CrystFEL (c).
especially at low resolution (below30 A˚). Each of the media
also produces diffuse scattering and/or Debye–Scherrer rings
at 4–5 A˚ for LCP, 4–5 and 14 A˚ for mineral oil-based grease
and 4.2 and 3.77 A˚ for petroleum jelly. The low background of
agarose is not surprising considering that it is composed of
93% water and only 7% agarose, compared with 50% water
and 50% lipids in LCP and 100% oil in grease or petroleum
jelly.
The time available for data collection was limited to 4 h of
protein crystal screening beamtime at LCLS. A full data set
for PC crystals was collected using the vacuum setup at CXI
(Figs. 3 and 4) during this time as well as a brief test run on
PSII crystals. In addition, data were collected from PSII and
PSI during short test runs using the ambient-pressure setup
(Figs. 3 and 4). These complexes were chosen to demonstrate
that agarose is an excellent carrier medium that can be used
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Figure 5
2Fo  Fc electron-density maps of PC. (a) PC trimer composed of two subunits,  (blue) and  (green), (b) an -helix and loop from the  subunit
contoured at 2.0, (c) -helices from both subunits at 1.5 and (d) the chromophore of PC at 1.5
for SFX data collection from even the largest protein
complexes containing noncovalently bound cofactors
(Supplementary Figs. S3 and S4).
The statistics of the PC data set are shown in Table 1. In
72 min of data collection, we collected 41 100 crystal hits from
PC, of which 14 143 could be indexed in a hexagonal lattice
with unit-cell parameters a = b = 153.4, c = 39.6 A˚. A high
multiplicity is essential for the determination of accurate
structure factors by Monte Carlo integration (Kirian et al.,
2010) to average out the fluctuating parameters such as pulse
intensity, partiality of reflections and crystal size distribution.
The PC data set showed a high overall multiplicity of 250.6 and
a multiplicity of 12.5 in the highest resolution shell (2.63–
2.5 A˚). The structure was solved using molecular replacement
and the structure was refined with final values of Rwork =
18.7% and Rfree = 25.2% (see x2). Fig. 5 shows the electron-
density map for the loops and side chains from subunit 
(cyan) and subunit  (green), as well as a detailed view of
phycocyanobilin, the chromophore of PC.
4. Conclusion
In comparison to the commonly used GDVN liquid jet, which
consumes protein crystal suspension at 10–25 ml min1, the
agarose delivery method presented here delivers protein
crystals at a flow rate of only 160 nl min1, reducing net
protein consumption by two orders of magnitude. We have
shown that the agarose medium might be suitable as a general
delivery system for SFX of both soluble and membrane
protein crystals and that it is compatible with a wide range of
crystallization conditions as well as temperatures. The agarose
jet can be used both in vacuum and at ambient pressure; so far,
the stream has displayed better stability in vacuum. The
agarose medium features lower X-ray scattering background
compared with LCP or other viscous crystal delivery media
such as mineral oil-based grease and petroleum jelly, espe-
cially at low resolution. Thus, agarose is an ideal SFX crystal
delivery medium for protein crystals with large unit cells and
medium-to-low resolution limits. The agarose delivery system
is a low-cost, readily available medium for sample delivery of
crystals of soluble and membrane protein complexes and is
compatible with most commonly used precipitants, including
various PEGs as well as high-salt conditions. Here, we have
demonstrated that crystals can be embedded into the agarose
medium post-crystallization. Furthermore, low sample
consumption extends the SFX method towards protein
complexes that are difficult to express and isolate in large
amounts. Thus, this technique will allow structures of scarce
proteins and systems that are difficult to crystallize in large
quantities to be investigated by serial femtosecond crystallo-
graphy.
Acknowledgements
This work was supported by the STC Program of the National
Science Foundation through BioXFEL under Agreement
No. 1231306 (PF, CEC, S. Basu, GN, GS, JC and JCHS),
the National Institutes of Health Femtosecond Nano-
crystallography of Membrane Proteins Award 617095583 (PF,
CEC, DW and JC), the Centre for Applied Structure
Discovery (PF and SRC), NIH grant U54GM094599 (PF and
JZ), NIGMS grant R01 GM108635 (VC), DOE DE-
SC0010575 (RF) and GM097463 (GN). Use of the Linac
Coherent Light Source (LCLS), SLAC National Accelerator
Laboratory, is supported by the US Department of Energy,
Office of Science, Office of Basic Energy Sciences under
Contract No. DE-AC02-76SF00515. We would also like to
thank Mark Holl for his helpful comments in regard to the
manuscript.
References
Aquila, A. et al. (2012). Opt. Express, 20, 2706–2716.
Arnott, S., Fulmer, A., Scott, W. E., Dea, I. C., Moorhouse, R. & Rees,
D. A. (1974). J. Mol. Biol. 90, 269–284.
Barty, A. et al. (2012). Nat. Photonics, 6, 35–40.
Barty, A., Kirian, R. A., Maia, F. R. N. C., Hantke, M., Yoon, C. H.,
White, T. A. & Chapman, H. (2014). J. Appl. Cryst. 47, 1118–1131.
Biertu¨mpfel, C., Basquin, J., Suck, D. & Sauter, C. (2002). Acta Cryst.
D58, 1657–1659.
Botha, S., Nass, K., Barends, T. R. M., Kabsch, W., Latz, B.,
Dworkowski, F., Foucar, L., Panepucci, E., Wang, M., Shoeman,
R. L., Schlichting, I. & Doak, R. B. (2015). Acta Cryst. D71,
387–397.
Boutet, S. et al. (2012). Science, 337, 362–364.
Boutet, S. & Williams, G. J. (2010). New J. Phys. 12, 035024.
Brehm, W. & Diederichs, K. (2014). Acta Cryst. D70, 101–109.
Caffrey, M. (2015). Acta Cryst. F71, 3–18.
Caffrey, M. & Cherezov, V. (2009). Nat. Protoc. 4, 706–731.
Chapman, H. N. et al. (2011). Nature (London), 470, 73–77.
Cheng, A., Hummel, B., Qiu, H. & Caffrey, M. (1998). Chem. Phys.
Lipids, 95, 11–21.
Cherezov, V. (2011). Curr. Opin. Struct. Biol. 21, 559–566.
DePonte, D. P., Weierstall, U., Schmidt, K., Warner, J., Starodub, D.,
Spence, J. C. H. & Doak, R. B. (2008). J. Phys. D Appl. Phys. 41,
195505.
Fenalti, G. et al. (2015). Nat. Struct. Mol. Biol. 22, 265–268.
Fromme, P. & Witt, H. T. (1998). Biochim. Biophys. Acta, 1365,
175–184.
Garcı´a-Ruiz, J. M., Novella, M. L., Moreno, R. & Gavira, J. A. (2001).
J. Cryst. Growth, 232, 165–172.
Hopkins, A. L. & Groom, C. R. (2002). Nat. Rev. Drug Discov. 1,
727–730.
Hunter, M. S. & Fromme, P. (2011). Methods, 55, 387–404.
Johansson, L. C. et al. (2013). Nat. Commun. 4, 2911.
Johansson, L. C. et al. (2012). Nat. Methods, 9, 263–265.
Jordan, P., Fromme, P., Witt, H. T., Klukas, O., Saenger, W. & Krauis,
N. (2001). Nature (London), 411, 909–917.
Karplus, P. A. & Diederichs, K. (2012). Science, 336, 1030–1033.
Kirian, R. A., Wang, X., Weierstall, U., Schmidt, K. E., Spence, J. C.,
Hunter, M., Fromme, P., White, T., Chapman, H. N. & Holton, J.
(2010). Opt. Express, 18, 5713–5723.
Kirian, R. A., White, T. A., Holton, J. M., Chapman, H. N., Fromme,
P., Barty, A., Lomb, L., Aquila, A., Maia, F. R. N. C., Martin, A. V.,
Fromme, R., Wang, X., Hunter, M. S., Schmidt, K. E. & Spence,
J. C. H. (2011). Acta Cryst. A67, 131–140.
Kissick, D. J., Wanapun, D. & Simpson, G. J. (2011). Annu. Rev. Anal.
Chem. 4, 419–437.
Kupitz, C. et al. (2014). Nature (London), 513, 261–265.
Landau, E. M. & Rosenbusch, J. P. (1996). Proc. Natl Acad. Sci. USA,
93, 14532–14535.
Lawrence, R. M., Conrad, C. E., Grant, T. D., Zatsepin, N. A., Liu, H.,
James, D., Nelson, G., Subramanian, G., Aquila, A., Hunter, M. S.,
research papers
IUCrJ (2015). 2, 421–430 Chelsie E. Conrad et al.  Inert crystal delivery medium for SFX 429
Liang, M., Boutet, S., Coe, J., Spence, J. C. H., Weierstal, U., Liu, W.,
Fromme, P., Cherezov, V., Snell, E. & Hogue, B. G. (2015).
Submitted.
Liu, W. et al. (2013). Science, 342, 1521–1524.
Lorber, B., Sauter, C., The´obald-Dietrich, A., Moreno, A., Schellen-
berger, P., Robert, M.-C., Capelle, B., Sanglier, S., Potier, N. &
Giege´, R. (2009). Prog. Biophys. Mol. Biol. 101, 13–25.
McCoy, A. J. (2007). Acta Cryst. D63, 32–41.
Neutze, R., Huldt, G., Hajdu, J. & van der Spoel, D. (2004). Radiat.
Phys. Chem. 71, 905–916.
Saridakis, E. & Chayen, N. E. (2003). Biophys. J. 84, 1218–
1222.
Schirmer, T., Bode, W., Huber, R., Sidler, W. & Zuber, H. (1985). J.
Mol. Biol. 184, 257–277.
Sierra, R. G. et al. (2012). Acta Cryst. D68, 1584–1587.
Sugahara, M. et al. (2015). Nat. Methods, 12, 61–63.
Weierstall, U. et al. (2014). Nat. Commun. 5, 3309.
White, T. A., Kirian, R. A., Martin, A. V., Aquila, A., Nass, K., Barty,
A. & Chapman, H. N. (2012). J. Appl. Cryst. 45, 335–341.
Zhang, H. et al. (2015). Cell, 61, 833–844.
research papers
430 Chelsie E. Conrad et al.  Inert crystal delivery medium for SFX IUCrJ (2015). 2, 421–430
